Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
MNPR Monopar Therapeutics
- 27.9500
- -0.4900-1.72%
Close Mar 10 16:00 ET
170.57MMarket Cap-14.12P/E (TTM)
29.8700High27.0500Low30.44KVolume28.6500Open28.4400Pre Close862.14KTurnover0.88%Turnover RatioLossP/E (Static)6.10MShares54.300052wk High34.46P/B96.93MFloat Cap1.715052wk Low--Dividend TTM3.47MShs Float240.0000Historical High--Div YieldTTM9.92%Amplitude1.3695Historical Low28.3240Avg Price1Lot Size
Monopar Therapeutics Key Stats
EPS
According to the latest financial report of Monopar Therapeutics, the latest earnings per share (TTM) for the company is -0.37. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Monopar Therapeutics's free cash flow? The latest report shows it as -1.07M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Monopar Therapeutics shows that the company's current ratio is 5.41, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Monopar Therapeutics, the quick ratio is 5.36, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Monopar Therapeutics? The latest ROE figure is -23.63%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Monopar Therapeutics, the total asset return on investment (ROA) is -19.69%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Monopar Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Monopar Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...